Table 3.
Quantile Regression on the Relationship Between MS and UCS Vitamin B12 and Folate Levels (β, 95% CI)
Quantiles | Model 1a | Model 2b | Model 3c | |||
---|---|---|---|---|---|---|
UCS Vitamin B12 | UCS Folate | UCS Vitamin B12 | UCS Folate | UCS Vitamin B12 | UCS Folate | |
10 | 0.95* (0.79, 1.10) | 0.25* (0.16, 0.34) | 0.98* (0.84, 1.12) | 0.27* (0.19, 0.35) | 0.89* (0.75, 1.03) | 0.25* (0.16, 0.35) |
20 | 1.09* (0.96, 1.22) | 0.32* (0.26, 0.39) | 1.11* (0.97, 1.25) | 0.33* (0.26, 0.39) | 1.08* (0.95, 1.22) | 0.33* (0.27, 0.39) |
30 | 1.29* (1.15, 1.43) | 0.33* (0.29, 0.37) | 1.34* (1.19, 1.49) | 0.33* (0.28, 0.37) | 1.24* (1.09, 1.38) | 0.32* (0.27, 0.37) |
40 | 1.57* (1.41, 1.73) | 0.31* (0.27, 0.35) | 1.55* (1.39, 1.72) | 0.31* (0.27, 0.35) | 1.36* (1.19, 1.53) | 0.30* (0.25, 0.34) |
50 | 1.75* (1.58, 1.93) | 0.28* (0.24, 0.32) | 1.84* (1.66, 2.02) | 0.28* (0.24, 0.32) | 1.68* (1.49, 1.86) | 0.28* (0.24, 0.33) |
60 | 2.05* (1.82, 2.28) | 0.26* (0.22, 0.30) | 2.09* (1.87, 2.32) | 0.27* (0.23, 0.31) | 1.89* (1.66, 2.13) | 0.27* (0.23, 0.31) |
70 | 2.53* (2.28, 2.78) | 0.27* (0.22, 0.32) | 2.56* (2.31, 2.81) | 0.27* (0.22, 0.32) | 2.41* (2.15, 2.68) | 0.28* (0.23, 0.33) |
80 | 2.68* (2.42, 2.94) | 0.33* (0.15, 0.52) | 2.87* (2.63, 3.11) | 0.33* (0.14, 0.52) | 2.58* (2.32, 2.84) | 0.37* (0.18, 0.56) |
90 | 3.11* (2.59, 3.63) | 1.20* (0.75, 1.66) | 3.07* (2.52, 3.62) | 1.21* (0.77, 1.65) | 2.95* (2.39, 3.52) | 1.04* (0.66, 1.43) |
OLS | 1.76* (1.57, 1.95) | 0.38* (0.30, 0.46) | 1.81* (1.63, 2.00) | 0.38* (0.30, 0.46) | 1.68* (1.49, 1.87) | 0.38* (0.30, 0.46) |
Notes: aModel 1 did not adjust for covariates. bModel 2 adjusted for gestational age. In addition to the above covariates, analysis of folate levels adjusted the levels of MS vitamin B12. cModel 3 adjusted for socio-demographic characteristics (maternal residence, maternal age, maternal educational level, neonatal gender, gestational age, and parity) and maternal health-related factors from 3 months before pregnancy to delivery (passive smoking, cold, and folic acid supplementation). In addition to the above covariates, analysis of folate levels adjusted the levels of MS vitamin B12. *P <0. 001.